GHEUENS SARAH (Chief Medical Officer) sold 4.5% of their position (4.01K shares) of AGIOS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $150.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/2/2026ACC: 0001439222-26-000110
Officer· Chief Medical Officer
Since Sep 2021
-4.01K
Net shares
Net seller
$150.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
8.38K acquired · 12.38K disposed
Non-Derivative Transactions2
Common stock
Direct
Shares
+8.38K
Price / share
—
Trade value
—
% of position
10.4%
7/1/2026
80.28K→88.65K
Common stock
Direct
Shares
−4.01K
Price / share
$37.56
Trade value
$150.50K
% of position
4.5%
7/1/2026
88.65K→84.64K
Total
Net shares
+4.37K
Net value
-$150.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 7/1/2026 | M · Option Exercise | +8.38K | — | — | 10.4% | 80.28K | 88.65K |
| Common stock Direct | 7/1/2026 | S · Sale | −4.01K | $37.56 | $150.50K | 4.5% | 88.65K | 84.64K |
| Total | +4.37K | -$150.50K | ||||||
Derivative Transactions1
Restricted stock units
Direct
Converts to
Common stock
8.38K shares
Shares
−8.38K
Strike price
Held after
0.00
Exercisable
—
7/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted stock units Direct | Common stock8.38K shares | 7/1/2026 | M · Option Exercise | −8.38K | — | 0.00 |